Companion Diagnostics: From Biomarker Identification to Market Entry

Wednesday, April 30, 2014 at 7:00am to 7:00pm

250 greenwich st

The recent growth in complex biological data has enabled a major paradigm shift in healthcare away from "one-size-fits-all" approaches towards customized, patient-tailored therapies. Biomarker-based companion diagnostics (CDx), designed to identify responsive patient sub-populations or those likely to experience adverse drug effects, lie at the heart of this personalized, precision medicine movement.

This 2-day conference will provide a neutral forum for international scientists and clinicians from academia, industry, and government — as well as healthcare policy makers, regulatory experts, insurance sector representatives, and other stakeholders — to discuss research, financial, and regulatory strategies that will facilitate CDx development and integration into clinical care. Presentations will illustrate successes and failures based on case studies; evaluate emerging applications of technologies such as epigenetics, bioinformatics, and nanotechnology; analyze diverse therapeutic target areas including the pioneering field of cancer along with inflammatory, infectious, cardiovascular, metabolic, and neurodegenerative diseases; recognize regulatory hurdles; and formulate solutions to better improve public health with CDx and personalized medicine.

Event Type

Basic Science




Event Contact Name

Tristan Morgan

Event Contact Email

Event Contact Phone


Recent Activity

People Going

Getting Here